产品描述
Cysteamine bitartrate (Mercaptamine bitartrate)是FDA批准的胱氨酸消耗氨基硫醇药物(cystine-depleting aminothiol agent),通过参与二硫交换减少溶酶体胱氨酸的积累,用于治疗肾病性胱氨酸病。此外,Cysteamine bitartrate还具有抗氧化特性。
Cas No.
27761-19-9
分子式
C6H13NO6S
分子量
227.24
别名
Mercaptamine bitartrate;Cysteamine bitartrate
储存和溶解度
(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years